Malaria and macrophage function in Africans: A possible link with autoimmune disease?

Medical Hypotheses

Volumn 47, Issue 2, 1996, Pages 97-100

  Butcher, G A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

AFRICA; AUTOIMMUNITY; DIAGNOSIS; DISEASE PREDISPOSITION; EPIDEMIOLOGY; ETIOLOGY; GENOTYPE; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MALARIA; PRIORITY JOURNAL; SARCOIDOSIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM; UNITED STATES;

EID: 0029777434     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90446-6     Document Type: Article

References (35)

1. Johnson A E, Gordon C, Palmer R G, Bacon P A. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthr Rheum 1995; 38: 551-558.
2. McNicol M W. Sarcoidosis. In: Cruickshank J, Beevers D, eds. Ethnic Factors in Health and Disease. London: Wright, 1989: 209-215.
3. Greenwood B M. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968; i: 380-382.
4. Dessien PHMC, Gledhill R F, Rossouw D S. Systemic lupus erythematosus in black South Africans. S Afr Med J 1988; 74: 387-389.
5. Nickle S P, Freeman R R, Cole G A. Depression of virus-specific cytotoxic T-cell reponses during murine malaria. Parasite Immunol 1987; 9: 161-174.
6. de Thè G. The etiology of Burkitt's lymphoma and the history of shaken dogmas. Blood Cells 1993; 19: 667-673.
7. Yorston D, Foster A. Herpetic keratin's in Tanzania: association with malaria. Br J Opthalmol 1992; 76: 582-585.
8. Becker FT. Malaria as a therapeutic agent. In: Boyd M F, ed. Malariology. Philadelphia, P A: W B Saunders, 1949: 1145-1157.
9. Greenwood B M, Voller A. Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. Clin Exp Immunol 1970; 7: 793-803.
10. Rockett K A, Awburn M M, Rockett E J, Cowden W B, Clark I A. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 1994; 16: 243-249.
11. Gordon C, Wofsy D. Effects of recombinant murine tumor necrosis factor-α on immune function. J Immunol 1990; 144: 1753-1758.
12. Peyron F, Vuillez J P, Barbe G, Boudin C, Picot S, Ambroise-Thomas P. Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria. Acta Trop Basel 1990; 47: 47-51.
13. Marsh K, Forster D, Warviru C et al. Indicators of life-threatening malaria in African children. New Engl J Med 1995; 332: 1399-1404.
14. Watkinson M, Rushton D I. Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers. Br Med J 1983; 287: 251-253.
15. Miller L H. Impact of malaria on genetic polymorphisms and genetic diseases in Africans and Afro-Americans. Proc Natl Acad Sci USA 1994; 91: 2415-2419.
16. Reibnegger G, Fuchs D, Hausen A, Schmutzard E, Werner E R, Wachter H. The dependence of cell-mediated immune activation in malaria on age and endemicity. Trans Roy Soc Trop Med Hyg 1987; 81: 729-733.
17. Kwiatkowski D, Cannon J D, Manogue K R, Cerami A, Dinarello C A, Greenwood B M. Tumour necrosis factor in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989; 77: 361-366.
18. Melancon-Kaplan J, Weidanz W P. Role of cell-mediated immunity in resistance to malaria. In: Stevenson M M, ed. Malaria: Host Responses to Infection. Boca Raton, FL: CRC, 1989: 37-63.
19. +4 T-cells in the immune response to Plasmodium chabaudi. Parasitol Today 1989; 5: 362-364.
20. Kwiatkowski D, Hill A V S, Sambou I et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336: 1201-1204.
21. Powell R D, McNamara J V, Reickman K H. Clinical acquisition of immunity to falciparum malaria. Proc Helminth Soc Wash 1972; 39 (Special issue): 51-66.
22. Kitchen S F. The infection in the intermediate host: symptomology, falciparum malaria. In: A Symposium on Malaria Pub 15, Washington DC; Am Ass Adv Sci 1941: 196-207.
23. McPeek M, Salkowitz J, Laufman H, Pearl D, Zwilling B S. The expression of HLA-DR by monocytes from black and from white donors: different requirements for protein synthesis. Clin Exp Immunol 1992; 87: 163-168.
24. McGuire W, Hill A V S, Allsopp C E, Greenwood B M, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
25. Turini F, Schwarzer E, Arese P. The involvement of hemozoin toxicity in depression of cellular immunity. Parasitology Today 1993; 9: 297-300.
26. Weissler J C. Southwestern Internal Medicine Conference: sarcoidosis: immunology and clinical management. Am J Med Sci 1994; 307: 233-245.
27. Spiteri M A, Clarke S W, Poulter L W. Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis. Europ Resp J 1992; 5: 394-403.
28. Jacob C, Fronek Z, Lewis G D et al. Heritable major histocompatible complex Class II-associated differences in production of tumour necrosis factor-α: relation to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.
29. Mitimura K, Kang H F, Tomita Y, Hashimoto H, Sawada S, Horie T. Impaired tumour necrosis factor-α (TNF-α) production and abnormal B cell response to TNF in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 85: 386-391.
30. Yu C L, Chang C-C, Chiu B N, Chiang B N, Han S-H, Wang S-R. Defective phagocytosis, decreased tumour necrosis factor-α production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections. Scand J Rheumatol 1989; 18: 97-105.
31. Wilson A G, Gordon C, di Giovine F S et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191-195.
32. Mays E E. Pulmonary diseases. In: Williams R A, ed. Textbook of Black-Related Diseases. New York: McGraw Hill, 1975: 416-437.
33. Stead W. Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering? Ann Intern Med 1992; 116: 937-941.
34. Ampel N M. In vitro production of tumour necrosis factor alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules. Cell Immunol 1994; 153: 248-255.
35. Rook G A. Macrophages and Mycobacterium tuberculosis: the key to pathogenesis. In: Zwilling B S, Eisenstein T K, eds. Macrophage-Pathogen Interactions. New York: Marcel Dekker, 1994: 249-262.